Phathom Pharmaceuticals Inc (US: PHAT) — Healthcare · Share Price, Chart & Market Data
About: Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $11.70 (-3.78%)
PHATPhathom Pharmaceuticals Inc
Loading watchlist status…
Trade PHAT now
Phathom Pharmaceuticals Inc share price
PHAT price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:24 am GMT+0
PHAT price performance
-9.161%
5D
10.586%
1M
-25.525%
YTD
181.928%
1Y
PHAT price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:24 am GMT+0
PHAT details
PHAT Market Signals